Vicki Goodman, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Recursion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RXRX alertsAbout Vicki Goodman, M.D.
Recursion Pharmaceuticals, Inc. reported in an 8-K filed March 25, 2026 that Vicki Goodman, M.D. was appointed Chief Medical Officer, effective April 6, 2026. Recursion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Recursion Pharmaceuticals, Inc. includes Christopher C. Gibson (CEO and Board Member), Najat Khan (CEO), Najat Khan, Ph.D. (CEO and Board Member) and 7 others.
“On March 25, 2026, Recursion Pharmaceuticals, Inc. (the "Company") announced that Vicki Goodman, M.D., will become Recursion's Chief Medical Officer effective April 6, 2026, as David Mauro, M.D., Ph.D. transitions out of the role.”
Affiliation history
-
Current
2026-04-06–present
Company network
Leadership on record at Recursion Pharmaceuticals, Inc.
- Christopher C. Gibson CEO, Board Member
- Najat Khan CEO
- Najat Khan, Ph.D. CEO, Board Member
- Christopher Gibson, Ph.D. Chairman
- Robert Hershberg, M.D., Ph.D. Chairman
- Ben Taylor CFO
- Kristen Rushton COO
- Tina Marriott COO
- David Hallett CTO, Board Member
- Blake Borgeson Board Member